Download PDF
1 / Pages

Other users also viewed these articles

COVID-19 and liver disease: An update Luis Téllez; Rosa María Martín Mateos;
Gastroenterol Hepatol. 2020;43:472-80
mTOR inhibitors a potential predisposing factor for chronic hepatitis E: Results from the prospective collaborative CHES study (Chronic Hepatitis E Screening in patients with immune impairment and increased transaminases levels) Mar Riveiro-Barciela; Luisa Roade; Joan Martínez-Camprecios; Judit Vidal-González; Basilio Rodríguez-Diez; Manel Perelló; Guillermo Ortí; Virginia Robles-Alonso; Cristina Berastegui; Jordi Navarro; Fernando Martínez-Valle; Itxarone Bilbao; Lluis Castells; Meritxell Ventura-Cots; Jordi Llaneras; Ariadna Rando-Segura; Xavier Forns; Sabela Lens; Martín Prieto; María García-Eliz; Arkaitz Imaz; Francisco Rodríguez-Frías; Maria Buti; Rafael Esteban;
Gastroenterol Hepatol. 2023;46:764-73
Involvement of the digestive system in COVID-19. A review Patricia Sanz Segura; Yolanda Arguedas Lázaro; Sonia Mostacero Tapia; Tomás Cabrera Chaves; Juan José Sebastián Domingo;
Gastroenterol Hepatol. 2020;43:464-71